Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000053417-16-000321
Filing Date
2016-02-05
Accepted
2016-02-05 14:17:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G AMENDED ANNUAL FILING - (PETX) petx1215.txt SC 13G/A 8092
  Complete submission text file 0000053417-16-000321.txt   9663
Mailing Address 466 LEXINGTON AVE NEW YORK NY 10017
Business Address 466 LEXINGTON AVE NEW YORK NY 10017 2124211000
JENNISON ASSOCIATES LLC (Filed by) CIK: 0000053417 (see all company filings)

EIN.: 132631108 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Subject) CIK: 0001509190 (see all company filings)

EIN.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87524 | Film No.: 161391646
SIC: 2834 Pharmaceutical Preparations